Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Liver Values Elevated in Overweight Children with Gene Mutation

By LabMedica International staff writers
Posted on 07 Jul 2014
Genetic polymorphism has been strongly associated with liver fat content and plasma alanine aminotransferase levels in obese adults and children, but little is known about these relationships in normal weight individuals.

Plasma levels of liver enzymes alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) that are widely used in clinical practice for the diagnostics of liver diseases have also been suggested as useful tools in the screening for pediatric non-alcoholic fatty liver disease (NAFLD).

Scientists at the University of Eastern Finland (Kuopio, Finland) studied a population sample of 481 Caucasian children aged 6 to 8 years who were examined at baseline and 419 children reexamined after two year follow-up. Altogether, 58 (12%) of 481 children at baseline and 71 (17%) of 419 children (205 girls and 214 boys) after 2-year follow-up were overweight.

Kinetic methods were used to analyze plasma activities of ALT and GGT (Roche Diagnostics Co., Mannheim, Germany). Genomic DNA was isolated from the blood mononuclear cells using the QIAamp DNA Blood kit (Qiagen, Hilden, Germany). The Patatin-Like Phospholipase Domain Containing 3 (PNPLA3) allele rs738409 was genotyped using an allele-specific polymerase chain reaction (PCR) assay. PNPLA3 148M polymorphisms were also investigated.

Of the 481 children examined at baseline, 283 (58.8%) were 148I homozygotes, 173 (36.0%) were I148M heterozygotes and 25 (5.2%) were 148M homozygotes. Of the 419 children re-examined after 2-year follow-up, 244 (58.2%) were 148I homozygotes, 153 (36.5%) were heterozygotes and 22 (5.3%) were 148M homozygotes. There were no differences in the genotype distributions of the rs738409 polymorphism between normal weight children and overweight children. Overweight children had higher plasma ALT levels at baseline and after two year follow-up and a larger increase in plasma ALT activity during two year follow-up than normal weight children adjusted for age, sex, body height, carrying the PNPLA3 148M allele.

The authors concluded that in healthy children the carriers of the 148M allele of the PNPLA3 rs738409 polymorphism have elevated plasma levels of ALT if they were overweight but not if they have a normal body weight. On the other hand, overweight children had higher plasma ALT levels than normal weight children even without the risk allele. These findings emphasize the early prevention of overweight particularly among children carrying the PNPLA3 148M allele to avoid liver fat accumulation and the development of NAFLD. The study was published on June 11, 2014, in the journal Pediatric Obesity.

Related Links:

University of Eastern Finland
Roche Diagnostics
Qiagen 



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.